Table 2.
Observed toxicity events for patients receiving trastuzumab plus pertuzumab
CTC Grade | ||||||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||||
Toxicity | N | % | N | % | N | % | N | % |
|
|
|
|
|||||
Hematologic | ||||||||
Neutropenia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hemoglobin | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
Thrombocytopenia | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 |
Nonhematologic | ||||||||
Diarrhea | 2 | 18 | 3 | 27 | 0 | 0 | 0 | 0 |
Allergic reaction | 2 | 18 | 0 | 0 | 1 | 9 | 0 | 0 |
Rash | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
Nail changes | 2 | 18 | 1 | 9 | 0 | 0 | 0 | 0 |
Left ventricular systolic Dysfunction | 3 | 27 | 2 | 18 | 1 | 9 | 0 | 0 |
N: number of patients.